AngioSoma, Inc. (OTCMKTS:SOAN) Files An 8-K Unregistered Sales of Equity Securities
ITEM 3.02 Unregistered Sales of Equity Securities.

On June 28, 2016, AngioSoma, Inc. (the “Company”) issued 1,498,124 shares of common stock to Crane Creek, Inc. in partial conversion of a convertible promissory note.  The shares were issued in reliance on Section 3(a)(9) and sold into the public markets in reliance on Section 4(a)(1) of the Securities Act of 1933 and Rule 144 thereunder.

On August 4, 2016, the Company issued 500,000 shares of common stock to NeuHaus Advisors, Inc. in partial conversion of a convertible promissory note.  The shares were issued in reliance on Section 3(a)(9) and sold into the public markets in reliance on Section 4(a)(1) of the Securities Act of 1933 and Rule 144 thereunder.

On September 28, 2016, the Company issued 1,500,000 shares of common stock to Desert Bloom Capital LTD in partial conversion of a convertible promissory note.  The shares were issued in reliance on Section 3(a)(9) and sold into the public markets in reliance on Section 4(a)(1) of the Securities Act of 1933 and Rule 144 thereunder.

On October 27, 2016, the Company issued 1,500,000 shares of common stock to Pinnacle Capital Partners LLC in partial conversion of a convertible promissory note.  The shares were issued in reliance on Section 3(a)(9) and sold into the public markets in reliance on Section 4(a)(1) of the Securities Act of 1933 and Rule 144 thereunder.

On November 1, 2016, the Company issued 1,000,000 shares of common stock to NeuHaus Advisors, Inc. in partial conversion of a convertible promissory note.  The shares were issued in reliance on Section 3(a)(9) and sold into the public markets in reliance on Section 4(a)(1) of the Securities Act of 1933 and Rule 144 thereunder.

AngioSoma, Inc. (OTCMKTS:SOAN) Recent Trading Information

AngioSoma, Inc. (OTCMKTS:SOAN) closed its last trading session 00.0000 at 0.0600 with shares trading hands.